No Impact of PolySia-NCAM Expression on Treatment Response in Neuroendocrine Neoplasms of the Lung.

Daniel GagiannisAnna ScheilSarah GagiannisCarsten HackenbrochRuediger HorstkorteKonrad Steinestel

Published in: Cancers (2022)

PolySia-NCAM expression was more common in high-grade compared to low-grade neuroendocrine neoplasms of the lung; however, this small pilot study failed to show an association between polySia-NCAM expression and response to therapy.

Keyphrases

low grade
high grade
poor prognosis
binding protein
bone marrow
mesenchymal stem cells
replacement therapy